CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 38 filers reported holding CONMED CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,177,080 | -33.0% | 4,463,000 | -12.6% | 0.00% | 0.0% |
| Q2 2023 | $7,722,825 | +26.8% | 5,106,000 | +2.2% | 0.00% | 0.0% |
| Q1 2023 | $6,089,000 | +105064.1% | 4,997,000 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $5,790 | -99.9% | 5,007,000 | +13.8% | 0.00% | 0.0% |
| Q3 2022 | $4,847,000 | +15.8% | 4,401,000 | +27.2% | 0.00% | 0.0% |
| Q2 2022 | $4,184,000 | +165.3% | 3,461,000 | +276.2% | 0.00% | – |
| Q1 2022 | $1,577,000 | +287.5% | 920,000 | +280.2% | 0.00% | – |
| Q4 2021 | $407,000 | +4422.2% | 242,000 | +3933.3% | 0.00% | – |
| Q3 2021 | $9,000 | -99.7% | 6,000 | -99.7% | 0.00% | – |
| Q2 2021 | $3,424,000 | +20.1% | 2,118,000 | +18.1% | 0.00% | – |
| Q1 2021 | $2,852,000 | +75.2% | 1,794,000 | +52.4% | 0.00% | – |
| Q4 2020 | $1,628,000 | +48.8% | 1,177,000 | +20.3% | 0.00% | – |
| Q3 2020 | $1,094,000 | -64.2% | 978,000 | -66.7% | 0.00% | -100.0% |
| Q2 2020 | $3,060,000 | – | 2,933,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mohican Financial Management, LLC | 2,840,000 | $3,958,000 | 4.02% |
| ZAZOVE ASSOCIATES LLC | 13,564,000 | $18,956,000 | 2.33% |
| SHENKMAN CAPITAL MANAGEMENT INC | 10,584,000 | $15,014,000 | 1.57% |
| SSI INVESTMENT MANAGEMENT LLC | 8,349,000 | $11,673,000 | 0.83% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $12,528,000 | 0.75% |
| MACKAY SHIELDS LLC | 32,384,000 | $45,397,000 | 0.31% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 8,379,000 | $11,734,000 | 0.25% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,271,000 | $7,387,000 | 0.19% |
| Calamos Advisors LLC | 23,007,000 | $32,262,000 | 0.19% |
| WESTWOOD HOLDINGS GROUP INC | 10,200,000 | $14,415,000 | 0.17% |